Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B

Liver International

Volumn 36, Issue 1, 2016, Pages 24-30

  Lee, Hye Won ^a   Kang, Wonseok ^a,b   Kim, Beom Kyung ^a,b   Kim, Seung Up ^a,b   Park, Jun Yong ^a,b   Kim, Do Young ^a,b   Ahn, Sang Hoon ^a,b   Park, Young Nyun ^a   Han, Kwang Hyub ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Center   (South Korea)

Author keywords

Chronic hepatitis B; Fibrosis; Liver stiffness measurement; Red cell volume distribution width to platelet ratio

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; SERUM ALBUMIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BILIRUBIN BLOOD LEVEL; CHRONIC HEPATITIS B; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGESTIVE TRACT PARAMETERS; ERYTHROCYTE VOLUME; FEMALE; FIB 4 SCORE; HEMATOLOGICAL PARAMETERS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; PLATELET COUNT; PREDICTION; PREDICTIVE VALUE; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; RED BLOOD CELL DISTRIBUTION WIDTH; RED CELL VOLUME DISTRIBUTION WIDTH TO PLATELET RATIO; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPLEEN SIZE; TRANSIENT ELASTOGRAPHY; BIOPSY; BLOOD; COMPLICATION; DIMENSIONAL MEASUREMENT ACCURACY; ELASTOGRAPHY; LIVER; LIVER CIRRHOSIS; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; THROMBOCYTE COUNT;

ADULT; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; BIOPSY; DIMENSIONAL MEASUREMENT ACCURACY; ELASTICITY IMAGING TECHNIQUES; ERYTHROCYTE INDICES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 85018216263     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12935     Document Type: Article

References (30)

1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2: 395–403.
2. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373: 582–92.
3. Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol 2006; 101(Suppl 1): S1–6.
4. EASL clinical practice guidelines. Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167–85.
5. Liaw YF, Kao JH, Piratvisuth T, et al. Asian-Pacific con- sensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int 2012; 6: 531–61.
6. Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008; 2: 263–83.
7. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614–8.
8. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523–5.
9. Christiansen KM, Mossner BK, Hansen JF, et al. Liver stiffness measurement among patients with chronic hepa- titis B and C: results from a 5-year prospective study. PLoS ONE 2014; 9: e111912.
10. Vallet-Pichard A, Mallet V, Pol S. FIB-4: A simple, inexpensive and accurate marker of fibrosis in HCV-infected patients. Hepatology 2006; 44: 769; author reply -70.
11. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012; 142: 1293–302 e4.
12. Kim BK, Fung J, Yuen MF, Kim SU. Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol 2013; 19: 1890–900.
13. Kim SU, Lee JH, Kim do Y, et al. Prediction of liver- related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS ONE 2012; 7: e36676.
14. Chen B, Ye B, Zhang J, Ying L, Chen Y. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS ONE 2013; 8: e68780.
15. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43: 1317–25.
16. Wai CT, Greenson JK, Fontana RJ, et al. A simple nonin- vasive index can predict both significant fibrosis and cir- rhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518–26.
17. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409– 17.
18. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839–43.
19. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008; 6: 1315–41; quiz 286.
20. Suh B, Park S, Shin DW, et al. High liver fibrosis index FIB-4 highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatology 2014; 61: 1261–8
21. Koda M, Matunaga Y, Kawakami M, et al. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007; 45: 297–306.
22. Sebastiani G, Castera L, Halfon P, et al. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther 2011; 34: 1202–16.
23. Afdhal NH, Bacon BR, Patel K, et al. Accuracy of fibro- scan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a US multi-center study. Clin Gastroenterol Hepatol 2014; 13: 772–9.
24. Wong GL. Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol Rep (Oxf) 2013; 1: 19–26.
25. Myers RP, De Torres M, Imbert-Bismut F, et al. Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index. Dig Dis Sci 2003; 48: 146–53.
26. Jin W, Lin Z, Xin Y, et al. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol 2012; 12: 14.30
27. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the pre- diction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007; 46: 912–21.
28. Chang PE, Lui HF, Chau YP, et al. Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index. Aliment Phar- macol Ther 2008; 28: 51–61.
29. Rickard J, Kumbhani DJ, Gorodeski EZ, et al. Elevated red cell distribution width is associated with impaired reverse ventricular remodeling and increased mortality in patients undergoing cardiac resynchronization therapy. Congest Heart Fail 2012; 18: 79–84.
30. Lou Y, Wang M, Mao W. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS ONE 2012; 7: e37644